Affordable Access

Recurrence of choroidal melanoma after Ru- 106 brachytherapy.

Authors
  • Bogdali, Anna
  • Romanowska-Dixon, Bozena
Type
Published Article
Journal
Klinika oczna
Publication Date
Sep 01, 2016
Volume
117
Issue
4
Pages
249–252
Identifiers
PMID: 29727111
Source
Medline
Language
Polish
License
Unknown

Abstract

The aim of the study was to analyse the recurrence rates of choroidal melanoma treated with Ru-106 brachytherapy with or without adjunctive transpupillary thermotherapy. We analysed medical records of 97 patients treated with Ru-106 brachytherapy with or without adjunctive transpupillary thermotherapy who subsequently presented with recurrence. All patients were treated at the Department of Ophthalmology and Ocular Oncology in Krak6w between 1995 and 2006. The mean time to recurrence was 29.15 months and tended to be shorter in larger melanomas. The 5-year recurrence rate determined using Kaplan-Meier estimator was 28.69%. Marginal recurrence was the most common type of recurrence, especially in tumors adjacent to the optic disc. The recurrence rates were the highest for all types of recurrence after the use of COB plaque with or without adjunctive transpupillary thermotherapy. The highest incidence of recurrence was shown in the second year following the Ru-106 brachytherapy and the time to recurrence tended to be shorter in larger melanomas. Marginal recurrence was the most common type of recurrence, especially in tumors adjacent to the optic disc.

Report this publication

Statistics

Seen <100 times